Protalix BioTherapeutics (PLX)

Protalix BioTherapeutics (PLX) stock research: performance, analysts' price targets, earnings, revenue and margins, technicals and insider trades.

• PLX last traded at $2.88, 12.06% on the day.
• Protalix BioTherapeutics: market cap $232.05M, P/E 11.3, revenue $84.69M over the last four quarters.
• Over the past year PLX returned 31.51%; year to date 60.00%.

Updated 2026-11-10 15:53 UTC